We are live on ! Find out more
ESMC

Escalon Medical Corp
ESMC

Delisted

ESMC was delisted on the 17th of November, 2016.

Back to rankings

1 hedge funds and large institutions have $2K invested in Escalon Medical Corp in 2017 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more capital invested

Capital invested by funds: $1K → $2K (+$1K)

0% more funds holding

Funds holding: 1 → 1 (0)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PAM
Panagora Asset Management
Massachusetts
-$86
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
1
Panagora Asset Management
Massachusetts
$2K -$86 -342 -4%

ESMC Hedge Fund Activity: Q4 2017 in Review

1 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Escalon Medical Corp (ESMC) for Q4 2017, worth a combined $2K — up 100% from $1K a quarter earlier.

Fund positioning in ESMC was balanced in Q4 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Panagora Asset Management, cutting an estimated $86.

  • 1 institutional investor held Escalon Medical Corp (ESMC) as of Q4 2017, unchanged from Q3 2017.
  • Funds reported $2K of Escalon Medical Corp stock for Q4 2017, up 100% quarter-over-quarter.
  • 0 funds opened new Escalon Medical Corp positions in Q4 2017 and 0 closed out.
  • The largest Escalon Medical Corp seller in Q4 2017 was Panagora Asset Management, an estimated $86 sold.

Based on aggregated 13F filings for Q4 2017.